{"id":249992,"date":"2025-07-09T06:01:39","date_gmt":"2025-07-09T06:01:39","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/249992\/"},"modified":"2025-07-09T06:01:39","modified_gmt":"2025-07-09T06:01:39","slug":"lgs-new-ai-slashes-genetic-testing-time-to-under-1-minute","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/249992\/","title":{"rendered":"LG\u2019s new AI slashes genetic testing time to under 1 minute"},"content":{"rendered":"

\"Exaone Exaone Path 2.0 outperforms rival models in genetic mutation prediction accuracy. (LG AI Research) <\/p>\n

LG AI Research on Wednesday unveiled its next-generation artificial intelligence model, Exaone Path 2.0, which can diagnose diseases by analyzing patients\u2019 pathology images alone.<\/p>\n

This new AI model is expected to drastically reduce the time required for genetic testing from two weeks to under one minute, marking a step forward in the early diagnosis of diseases such as cancer.<\/p>\n

Exaone Path 2.0 has been upgraded from the first edition, trained on higher-quality data. It offers enhanced capabilities in analyzing and predicting genetic mutations, gene expression patterns and subtle structural features within human tissues and cells, the AI research center, affiliated with tech giant LG Group, said.<\/p>\n

\u201cUsing Exaone Path 2.0, we can reduce the time needed for genetic testing from over two weeks to under one minute,\u201d said Park Yong-min, a lead researcher at LG AI Research.<\/p>\n

\u201cDoctors and pharmaceutical companies can quickly analyze pathology images of a patient\u2019s tumor tissue, identify which genes have mutated and match them to suitable targeted therapies in real time.\u201d<\/p>\n

The latest model has been trained on multiomics data \u2014 including DNA and RNA \u2014 paired with pathology images, allowing it to understand both cellular structures and underlying biological mechanisms of disease, LG AI Research explained.<\/p>\n

As Whole Slide Images often span several gigabytes, AI models typically break them into smaller patches to reduce processing loads. This, however, can lead to \u201cfeature collapse,\u201d where broader structural context is lost.<\/p>\n

Exaone Path 2.0 addresses this by learning from both detailed patches and the full-slide view. Trained on over 10,000 WSI-multiomics pairs, it achieves a state-of-the-art 78.4 percent accuracy in predicting genetic mutations, LG explained.<\/p>\n

LG also introduced specialized models for diseases such as lung and colorectal cancer, which are designed to help clinicians identify eligible patient groups for targeted therapies while avoiding unnecessary tests.<\/p>\n

\"Hwang Hwang Tae-hyun, a professor at Vanderbilt University Medical Center (LG AI Research) <\/p>\n

With the goal of pioneering clinical AI implementation, LG AI Research has partnered with Professor Hwang Tae-hyun and his team at Vanderbilt University Medical Center, one of the top biomedical research institutions in the US.<\/p>\n

Together, they aim to develop a multimodal medical AI platform to redefine precision medicine, LG said.<\/p>\n

Unlike conventional approaches that first develop technologies and then seek clinical application, the research institute is working on a clinic-first strategy, focusing on solving real-world problems directly within clinical settings for AI development.<\/p>\n

\u201cOur goal is not simply to develop a new AI model, but to build an AI platform that can be actively used by medical professionals in real clinical settings to support diagnosis and treatment,\u201d Hwang said.<\/p>\n

Hwang is a Korean-American scientist who leads the stomach cancer initiative under the US government\u2019s Cancer Moonshot program. He also founded the Molecular AI Initiative at Vanderbilt University Medical Center, where he conducts interdisciplinary research at the intersection of AI and molecular medicine.<\/p>\n

With Hwang\u2019s team, LG AI Research said it plans to start with oncology and later expand its multimodal AI research into areas such as transplant rejection, immunology and diabetes.<\/p>\n

The research institute has also teamed up with the Jackson Laboratory in the US to discover biomarkers and develop treatments for Alzheimer\u2019s disease, and it is working with Professor Baek Min-kyung\u2019s team at Seoul National University to develop next-generation protein structure prediction AI.<\/p>\n

herim@heraldcorp.com<\/p>\n","protected":false},"excerpt":{"rendered":"Exaone Path 2.0 outperforms rival models in genetic mutation prediction accuracy. (LG AI Research) LG AI Research on…\n","protected":false},"author":2,"featured_media":249993,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3846],"tags":[15842,267,7299,15839,15838,31766,70,15840,15841,15837,16,15,15844,15845,15843],"class_list":{"0":"post-249992","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-asia-news","9":"tag-genetics","10":"tag-k-pop","11":"tag-koreaherald","12":"tag-korean-news","13":"tag-kpop","14":"tag-science","15":"tag-south-korea-news","16":"tag-south-korea-news-in-english","17":"tag-the-korea-herald","18":"tag-uk","19":"tag-united-kingdom","20":"tag-15844","21":"tag-15845","22":"tag-15843"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114821758224367905","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/249992","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=249992"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/249992\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/249993"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=249992"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=249992"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=249992"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}